EpiVacCorona: Russia’s second COVID-19 vaccine
Kathmandu. Russia has completed the second phase of vaccination against coronavirus. The vaccine named EpiVacCorona is being prepared at the Vektor State Research Center of Virology and Biotechnology in Siberia. The Center expressed on Thursday that the first two-phase trial of the vaccine had received good results. Russia had previously announced its first vaccine against coronavirus, Sputnik V, in August.
A kit has also been developed by Becton Dickinson & Co. that detects infection by identifying antigen proteins on the SARS-COV-2 surface. The kit requires a waiting time of 15-minutes and has been approved. It is expected that the kit will be sold in the European market from the last week of October.
Meanwhile, the number of coronavirus infections worldwide has reached more than 34.1 million. While more than 25.42 million have recovered, 1.18 million have succumbed to death.
Facebook Comment
Related News
latest Video
Trending News
- This Week
- This Month
